Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I

Virology

Volumn 245, Issue 1, 1998, Pages 90-98

  Blanchard, S ^a   Astier Gin, T ^a   Moynet, D ^a   Edouard, E ^b   Guillemain, B ^a  

^a INSERM   (France)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; SERUM; SYNCYTIUM;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 187;

EID: 0032565723     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9139     Document Type: Article

References (40)

1. Astier-Gin T., Portail J. P., Lafond F., Guillemain B. Identification of HTLV-I or HTLV-II infected cells by cocultivation with BHK-21 cells stably transfected with a LTR-LacZ gene construct. J. Virol. Methods. 51:1995;19-30.
2. Astier-Gin T., Portail J. P., Londos-Gagliardi D., Moynet D., Blanchard S., Dalibart R., Pouliquen J. F., Georges-Courbot M. C., Hajjar C., Sainte-Foie S., Guillemain B. Neutralizing activity and antibody reactivity toward immunogenic regions of the HTLV-I surface glycoprotein in sera of infected patients with different clinical status. J. Infect. Dis. 175:1997;716-719.
3. Baba E., Nakamura M., Ohkuma K., Kira J. I., Tanaka Y., Nakano S., Niho Y. A peptide based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induced titers of neutralizing antibodies. J. Immunol. 154:1995;399-412.
4. Benson J., Tschachler E., Gessain A., Yanagihara R., Gallo R. C., Franchini G. Cross-neutralizing antibodies against Cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. AIDS Res. Hum. Retroviruses. 10:1994;91-96.
5. Clapham P., Nagy K., Weiss R. A. Pseudotypes of human T-cell leukemia virus types 1 and 2: Neutralization by patients' sera. Proc. Natl. Acad. Sci. USA. 81:1984;2886-2889.
6. Denesvre C., Sonigo P., Corbin A., Ellerbrok H., Sitbon M. Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J. Virol. 69:1995;4149-4157.
7. Dezzutti C. S., Frazier D. E., Huff L. Y., Stromberg P. C., Olsen R. G. Subunit vaccine protects Macaca nemestrina (pig tailled Macaque) against simian T-cell lymphotropic virus type I challenge. Cancer Res. 50:1990;5687s-5691.
8. Edouard E., Londos-Gagliardi D., Busetta B., Geoffre S., Dalbon P., Moreau J. P., Guillemain B. Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I. Leukemia. 8:1994;S65-S67.
9. Ford C. M., Arp J., Palker T. J., King E. E., Dekaban G. A. Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: induction of neutralizing antibody. Virology. 191:1992;448-453.
10. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., De The G. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet. 11:1985;407-410.
11. Gessain A., Yanagihara R., Franchini G., Garruto R. M., Jenkins C. L., Adjukiewick A. B., Gallo R. C., Gajdusek D. C. Highly divergent molecular variants of human T lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc. Natl. Acad. Sci. USA. 88:1991;7694-7698.
12. Gray G. S., White M., Bartman T., Mann D. Envelope gene sequence of HTLV-I isolate MT-2 and its comparison with other HTLV-I isolates. Virology. 177:1990;391-395.
13. Hadlock K. G., Rowe J., Perkins S., Bradshaw P., Song G-Y., Cheng C., Yang J., Gascon R., Halmos J., Rehman S. M. M., McGrath M. S., Foung K. H. Neutralizing human monoclonal antibodies to conformational epitopes of human T-Cell lymphotropic virus type 1 and 2 gp46. J. Virol. 71:1997;5828-5840.
14. Hakoda E., Machida H., Tanaka Y., Norishita N., Sawada T., Shida H., Hoshino H., Miyoshi I. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int. J. Cancer. 60:1995;567-570.
15. Hart M. K., Palker T. J., Haynes B. F. Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infection. Vaccine Design: The Subunit and Adjuvant Approach. 1995;Plenum, New York. p. 821-845.
16. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA. 78:1981;6476-6480.
17. Hinuma Y., Komoda H., Chosa T., Kondo T., Kohakura M., Takenara T., Kikuchi M., Ichimura M., Yunoki K., Sato I., Matsuo R., Takiuchi Y., Uchino H., Hanaoka M. Antibodies to adult T-cell leukemia virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nationwide sero epidemiologic study. Int. J. Cancer. 29:1982;631-635.
18. Hoshino H., Clapham P. R., Weiss R. A., Myoshi I., Yoshida M., Miwa M. Human T cell leukemia virus type I: Pseudotype neutralization of Japanese and American isolates with human and rabbit sera. Int. J. Cancer. 36:1985;671-675.
19. Hoshino H., Nakamura T., Tanaka Y., Miyoshi I., Yanagihara R. Functional conservation of neutralizing domains on the external envelope glycoprotein of Cosmopolitan and Melanesian strains of human T cell leukemia/lymphoma virus type I. J. Infect. Dis. 168:1993;1368-1373.
20. Kalyanaraman V. S., Sangadharan M. G., Bunn P. A., Minna J. D., Gallo R. C. Antibodies in human sera reactive against an internal structural protein (p24) of human T lymphoma virus. Nature. 294:1981;271-273.
21. Kataoka R., Takehara N., Iwahara Y., Sawada T., Ohtsuki Y., Dawei Y., Hoshino H., Miyoshi I. Transmission of HTLV-I by blood transfusion and its prevention by passive immunisation in rabbit. Blood. 76:1990;1657-1661.
22. Kazanji M., Bomford R., Bessereau J-L., Schultz T., De The G. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene. Int. J. Cancer. 71:1997;300-307.
23. Malik K. T. A., Even J., Karpas A. Molecular cloning and complete nucleotide sequence of an adult T cell leukemia virus/human T cell leukemia virus type 1 (ATLV/HTLV-I) isolate of Caribbean origin: Relationship to other members of the ATLV/HTLV-I subgroup. J. Gen. Virol. 69:1988;1695-1710.
24. Minagawa H., Yoshida T., Itoyama Y., Mora C. A., Albert P., Mori R. Neutralizing antibodies against HTLV-I in HTLV-I associated myleopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers. Neurology. 42:1992;2210-2212.
25. Miyoshi I., Takehara N., Sawada T., Iwahara Y., Kataoka R., Yang D., Hoshino H. Immunoglobulin prophylaxis against HTLV-I in a rabbit model. Leukemia. 1:1992;24-26.
26. Moynet D., Cosnefroy J. Y., Bedjabaga I., Roelants G., Georges-Courbot M. C., Guillemain B. Identification of new genetic subtypes of human T cell leukemia virus type I in Gabon from encoding sequence of surface envelope glycoprotein. Aids Res. Hum. Retroviruses. 11:1995;1407-1411.
27. Nagy K., Clapham P., Cheingsong-Popov R., Weiss R. A. Human T-cell leukemia virus type I: Induction of syncytia and inhibition by patient sera. Int. J. Cancer. 32:1983;321-328.
28. Nakamura H., Hayami M., Ohta Y., Ishikawa K., Tsujimoto H., Kiyokawa T., Yoshida M., Sasagawa A., Honjo S. Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunisation with viral env produced inEscherichia coli. Int. J. Cancer. 40:1987;403-407.
29. Nicot C., Astier-Gin T., Edouard E., Legrand E., Moynet D., Vital A., Londos-Gagliardi D., Moreau J. P., Guillemain B. Establishment of HTLV-I infected cell lines from French Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res. 30:1993;317-334.
30. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1:1986;1031-1032.
31. Palker T. J., Riggs E. R., Spragion D. E., Muir A. J., Scearce R. M., Randall R. R., McKnight A., Clapham P. R., Weiss R. A., Haynes B. F. Mapping of homologous amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J. Virol. 66:1992;5879-5889.
32. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
33. Robert-Guroff M., Fahey K. A., Maeda M., Nakao Y., Ito Y., Gallo R. C. Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody. Virology. 122:1982;297-305.
34. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
35. Sawada T., Iwahara Y., Ishii K., Taguchi H., Hoshino H., Miyoshi I. Immunoglobulin prophylaxis against milkborn transmission of human T cell leukemia virus type I in rabbits. J. Infect. Dis. 164:1991;1193-1196.
36. Schulz T. F., Calabro M. L., Hoad J. G., Carrington C. V. F., Matutes E., Catovsky D., Weiss R. A. HTLV-I envelope sequences from Brazil, the Caribbean, and Rumania: Clustering of sequences according to geographic origin and variability in an antibody epitope. Virology. 184:1991;483-491.
37. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA. 80:1983;3618-3622.
38. Shida H., Tochikura T., Sato T., Konno T., Hirayoshi K., Seki M., Ito Y., Hatanaka M., Hinuma Y., Sugimoto M., Takahashi-Nishimaki F., Maruyama T., Miki K., Suzuki K., Morita M., Sashiyama H., Hayami M. Effect of recombinant vaccinia virus that express HTLV-I envelope gene on HTLV-I infection. EMBO J. 6:1987;3379-3384.
39. Tanaka Y. L., Zeng H., Shiraki H., Shida H., Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibodies by peptide immunization. J. Immunol. 147:1991;354-360.
40. Yoshida M., Miyoshi J., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 79:1982;2031-2035.